Israeli Biotech Acquires Microbiome Company to Fight Chronic Liver Disease
BiomX has acquired RondinX, expanding its bacterial target discovery platform and adding new microbiome targets…
The potential of the microbiome to be used for the development of promising therapeutics and diagnostic approaches has spurred a hype around this emerging field. Over the last decade, researchers have found correlations between the human microbiome and a number of diseases, including inflammatory bowel disease, diabetes, autoimmune diseases, cancer, depression, and many more. As the number of clinical trials grows, investor interest is increasing.
Read on to find out more about the flourishing microbiome field and how it shows promise for the treatment of a large variety of diseases.
Beyond the Gut: An Atlas of the Human Microbiome
This report discusses the role of the gut and blood microbiomes in different diseases and how they can be used for biomarker discovery and for the development of therapeutics.
Go to ReportBiomX has acquired RondinX, expanding its bacterial target discovery platform and adding new microbiome targets…
Biomillenia harnesses the power of bacteria to keep the body healthy. The biotech has joined…
LNC Therapeutics is ready to take its oral microbiome-based therapeutic to market for obesity. Investors…
Eligo Bioscience has announced its first fundraising round, amassing $20M (€18.5M) that will be put…
Da Volterra has been boosted by a €20M loan to speed up the development of solutions…
Bayer and Ginkgo Bioworks are launching a new company that will develop new technologies for…
Slovenian artists Saša Spačal, Mirjan Švagelj and Anil Podgornik explore the meaning of human identity by…
Microbiome Diagnostics Partners will develop diagnostics tests with Enterome's microbiome platform IP and a €20M…
After CRISPR, there's a new genetic technique with a tongue-in-cheek name in town: LASSO cloning. …
A whole new avenue to human health and disease could soon be accessible, thanks to…
A panel of experts at Microbiome Invest in London discussed the unlimited applications of the microbiome and how…
Personalized and democratized medicine is coming to the microbiome via a new initiative, FeelGut, from…